The mainstay of treatment for pseudohypoparathyroidism is oral calcium and 1alpha-hydroxylated vitamin D analogues, such as calcitriol. Other forms of Vitamin D cannot be used as parathyroid hormone resistance in the proximal tubule decreases the efficiency of production of 1,25(OH)2 vitamin D from 25-hydroxyvitamin D.Intravenous calcium is recommended for all patients who develop severe symptomatic hypocalcemia.
Pseudohypoparathyroidism medical therapy
Hypoparathyroidism medical therapy
Hyperparathyroidism medical therapy
Hypoparathyroidism surgery
Hypoparathyroidism future or investigational therapies
Pseudohypoparathyroidism surgery
Vitamin D deficiency medical therapy
Secondary adrenal insufficiency medical therapy